David Hastings
Overview
Explore the profile of David Hastings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Overholt W, Schwing P, Raz K, Hastings D, Hollander D, Kostka J
Environ Microbiol
. 2019 Aug;
21(11):4316-4329.
PMID: 31469487
The microbial ecology of oligotrophic deep ocean sediments is understudied relative to their shallow counterparts, and this lack of understanding hampers our ability to predict responses to current and future...
2.
McEachern K, Alegria H, Kalagher A, Hansen C, Morrison S, Hastings D
Mar Pollut Bull
. 2019 Aug;
148:97-106.
PMID: 31422308
This study provides the first measurement of microplastic abundance and distribution in surface waters and sediments in Tampa Bay, FL. Microplastic concentrations in discrete water samples ranged from 0.25 to...
3.
Williams H, Julyan P, Ranson M, Zweit J, Gillies J, Hastings D
Eur J Nucl Med Mol Imaging
. 2006 Nov;
34(2):301-3.
PMID: 17109169
No abstract available.
4.
Williams H, Robinson S, Julyan P, Zweit J, Hastings D
Eur J Nucl Med Mol Imaging
. 2005 Nov;
32(12):1473-80.
PMID: 16258764
Purpose: PET radiotracers which incorporate longer-lived radionuclides enable biological processes to be studied over many hours, at centres remote from a cyclotron. This paper examines the radioisotope characteristics, imaging performance,...
5.
Dekker B, Keen H, Shaw D, Disley L, Hastings D, Hadfield J, et al.
Nucl Med Biol
. 2005 May;
32(4):403-13.
PMID: 15878510
We are interested in imaging cell death in vivo using annexin V radiolabeled with (124)I. In this study, [(124)I]4IB-annexin V and [(124)I]4IB-ovalbumin were made using [(124)I]N-hydroxysuccinimidyl-4-iodobenzoate prepared by iododestannylation of...
6.
Keen H, Dekker B, Disley L, Hastings D, Lyons S, Reader A, et al.
Nucl Med Biol
. 2005 May;
32(4):395-402.
PMID: 15878509
Abnormal regulation of apoptosis is an important pathogenic mechanism in many diseases including cancer. Techniques to assess apoptosis in living organisms are limited and, in the case of solid organs,...
7.
MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET
Dekker B, Keen H, Lyons S, Disley L, Hastings D, Reader A, et al.
Nucl Med Biol
. 2005 Apr;
32(3):241-52.
PMID: 15820759
A noninvasive method of measuring programmed cell death in the tumors of cancer patients using positron-emission tomography (PET) would provide valuable information regarding their response to therapeutic intervention. Our strategy...
8.
Harris M, Julyan P, Kulkarni B, Gow D, Hobson A, Hastings D, et al.
J Cereb Blood Flow Metab
. 2005 Feb;
25(4):520-6.
PMID: 15689960
We have previously shown that labelled water positron emission tomography (H2(15)O PET) can be used to identify regional cerebral blood flow (rCBF) changes in the human brain during volitional swallowing....
9.
Jayson G, Zweit J, Jackson A, Mulatero C, Julyan P, Ranson M, et al.
J Natl Cancer Inst
. 2002 Oct;
94(19):1484-93.
PMID: 12359857
Background: Vascular endothelial growth factor (VEGF) is a potent angiogenic cytokine, and various inhibitory agents, including specific antibodies, have been developed to block VEGF-stimulated angiogenesis. We developed HuMV833, a humanized...